Thirty-five times more white patients than patients of color receive buprenorphine, and three-quarters of prescriptions go to those who pay cash or have private insurance
As Research & Policy Media Relations Manager at the U-M Institute for Healthcare Policy and Innovation (IHPI), Kara Gavin draws on 25 years of experience in communicating about science, medicine and health policy. Her responsibilities include creating compelling stories about discoveries made by the U-M Medical School's primary care, biomedical and mental health researchers, and the findings and opinions of the 600 healthcare wonks at the U-M IHPI.
Researchers cause a lupus-like disease in mice by amplifying the amount of a single “master regulator” factor — suggesting both a root cause for known differences between the sexes and a target for new treatments.
Standardizing measurement of the physical, social and emotional effects experienced by caregivers of people with a traumatic brain injury could lead to better support for an overlooked group.
A tool borrowed from bacteria successfully seeks out, cuts and destroys long stretches of human cells’ DNA, opening doors to new uses in research and treatment.
Hospitals put a lot of effort into encouraging good hand hygiene among staff. But findings about multidrug-resistant organisms suggest a new frontier for preventing transmission.
An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury in mice could be harnessed as a therapy or used as a biomarker.<